US Stock MarketDetailed Quotes
FBRX Forte Biosciences
- 15.608
- +2.058+15.18%
Trading Nov 21 15:42 ET
22.82MMarket Cap-952P/E (TTM)
15.930High10.110Low1.22MVolume12.250Open13.550Pre Close16.22MTurnover132.91%Turnover RatioLossP/E (Static)1.46MShares21.25052wk High2.44P/B14.34MFloat Cap4.11052wk Low--Dividend TTM918.91KShs Float6732.375Historical High--Div YieldTTM42.95%Amplitude4.110Historical Low13.278Avg Price1Lot Size
Forte Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -15.53%8.63M | 41.89%12.82M | 13.84%7.8M | 133.78%32.49M | 29.20%6.38M | 198.45%10.22M | 199.14%9.03M | 172.67%6.86M | -35.33%13.9M | 49.71%4.94M |
| Selling and administrative expenses | -28.28%2.76M | 273.51%7.08M | 66.88%3.45M | 27.97%10.62M | 14.81%2.81M | 88.21%3.85M | -4.58%1.9M | 13.56%2.07M | 8.76%8.3M | 25.89%2.45M |
| -General and administrative expense | -28.28%2.76M | 273.51%7.08M | 66.88%3.45M | 27.97%10.62M | 14.81%2.81M | 88.21%3.85M | -4.58%1.9M | 13.56%2.07M | 8.76%8.3M | 25.89%2.45M |
| Research and development costs | -7.83%5.87M | -19.60%5.74M | -9.07%4.35M | 290.81%21.86M | 43.37%3.57M | 361.86%6.37M | 590.43%7.14M | 590.76%4.79M | -59.62%5.59M | 84.02%2.49M |
| Operating profit | 15.53%-8.63M | -41.89%-12.82M | -13.84%-7.8M | -133.78%-32.49M | -29.20%-6.38M | -198.45%-10.22M | -199.14%-9.03M | -172.67%-6.86M | 35.33%-13.9M | -49.71%-4.94M |
| Net non-operating interest income expense | 593.83%1.12M | 162K | ||||||||
| Non-operating interest income | ---- | ---- | ---- | 593.83%1.12M | ---- | ---- | ---- | ---- | --162K | ---- |
| Other net income (expense) | -9.20%237K | 122.46%307K | 276.47%384K | 21.38%-114K | -515.00%-615K | 1,034.78%261K | 1,020.00%138K | 292.45%102K | 34.68%-145K | -138.10%-100K |
| Other non- operating income (expenses) | -9.20%237K | 122.46%307K | 276.47%384K | 21.38%-114K | -515.00%-615K | 1,034.78%261K | 1,020.00%138K | 292.45%102K | 34.68%-145K | -138.10%-100K |
| Income before tax | 15.70%-8.39M | -40.64%-12.51M | -9.88%-7.42M | -126.79%-31.48M | -20.40%-5.87M | -192.79%-9.96M | -193.11%-8.9M | -163.07%-6.75M | 36.07%-13.88M | -45.97%-4.88M |
| Income tax | ||||||||||
| Net income | 15.70%-8.39M | -40.64%-12.51M | -9.88%-7.42M | -126.79%-31.48M | -20.40%-5.87M | -192.79%-9.96M | -193.11%-8.9M | -163.07%-6.75M | 36.07%-13.88M | -45.97%-4.88M |
| Net income continuous Operations | 15.70%-8.39M | -40.64%-12.51M | -9.88%-7.42M | -126.79%-31.48M | -20.40%-5.87M | -192.79%-9.96M | -193.11%-8.9M | -163.07%-6.75M | 36.07%-13.88M | -45.97%-4.88M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 15.70%-8.39M | -40.64%-12.51M | -9.88%-7.42M | -126.79%-31.48M | -20.40%-5.87M | -192.79%-9.96M | -193.11%-8.9M | -163.07%-6.75M | 36.07%-13.88M | -45.97%-4.88M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 15.70%-8.39M | -40.64%-12.51M | -9.88%-7.42M | -126.79%-31.48M | -20.40%-5.87M | -192.79%-9.96M | -193.11%-8.9M | -163.07%-6.75M | 36.07%-13.88M | -45.97%-4.88M |
| Basic earnings per share | 30.90%-4.54 | 35.71%-6.75 | 50.00%-4 | -25.00%-25 | 82.83%-1.03 | -46.00%-6.57 | -100.00%-10.5 | -88.24%-8 | 48.39%-20 | -14.29%-6 |
| Diluted earnings per share | 30.90%-4.54 | 35.71%-6.75 | 50.00%-4 | -25.00%-25 | 82.83%-1.03 | -46.00%-6.57 | -100.00%-10.5 | -88.24%-8 | 48.39%-20 | -14.29%-6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
